Deferasirox for managing iron overload in people with myelodysplastic syndrome

BACKGROUND: The myelodysplastic syndrome (MDS) comprises a diverse group of haematopoietic stem cell disorders. Due to symptomatic anaemia, most people with MDS require supportive therapy including repeated red blood cell (RBC) transfusions. In combination with increased iron absorption, this contri...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Cochrane Database Syst Rev
Asıl Yazarlar: Meerpohl, Joerg J, Schell, Lisa K, Rücker, Gerta, Fleeman, Nigel, Motschall, Edith, Niemeyer, Charlotte M, Bassler, Dirk
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: John Wiley & Sons, Ltd 2014
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7202239/
https://ncbi.nlm.nih.gov/pubmed/25348770
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD007461.pub3
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller